CD8A and urinary bladder cancer: Additionally, in bladder cancer, the JNK signaling pathway promotes the expression of thymic stromal lymphopoietin in CAFs, which inhibits CD8+ T cell cytotoxicity and effector functions, ultimately contributing to immunotherapy resistance [178].